Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Analysts

Analysts

FirmAnalyst Phone
Bank of America Merrill Lynch
Derik de Bruin
Barclays Capital
Jack Meehan
Credit Suisse
Erin Wilson Wright
Deutsche Bank
Dan Leonard
Evercore ISI
Ross Muken
Goldman Sachs
Robert Jones
Jefferies
David Windley
J.P. Morgan
Tycho Peterson
KeyBanc Capital Markets
Donald Hooker
Morgan Stanley
Ricky Goldwasser
Morningstar
Anna Baran
Robert W. Baird
Eric Coldwell
SunTrust Robinson Humphrey
Sandy Draper
UBS
Daniel Brennan
William Blair
John Kreger
Wolfe Research
Stephen Baxter

Charles River Laboratories International, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Charles River Laboratories International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Charles River Laboratories International, Inc. or its management. Charles River Laboratories International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Quote

(common)
Price
Change (%)
 
Volume
Exchange
Data as of 08/04/19 3:51 am EDT
Copyright West LLC.
Minimum 15 minutes delayed.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)